Physician profile
Renee A Ryan
NPI 1386811545
$908.22
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $167 · 2021: $291 · 2022: $304.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $196.79 | 2021-2022 | |
| Advanced Oxygen Therapy INC. | $154.15 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $106.15 | 2019-2022 | |
| Integra Lifesciences Corporation | $97.22 | 2019-2022 | |
| Abbvie INC. | $76.80 | 2021-2022 | |
| Misonix INC | $55.28 | 2020-2021 | |
| Hydrofera LLC | $52.45 | 2022 | |
| Smith+Nephew, INC. | $49.41 | 2021-2022 | |
| Convatec INC. | $35.26 | 2021 | |
| Osiris Therapeutics INC. | $33.74 | 2019 | |
| Tactile Systems Technology INC | $21.53 | 2020 | |
| Allergan, INC. | $17.54 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $11.90 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.